Related Experiment Video
Updated: Jun 2, 2026

Fabrication of Tongue Extracellular Matrix and Reconstitution of Tongue Squamous Cell Carcinoma In Vitro
Published on: June 20, 2018
Cyclooxygenase-2 expression in oral tongue squamous cell carcinoma
Michael Ryott1, Linda Marklund, Darawalee Wangsa
1Department of Clinical Science, Intervention and Technology, Karolinska Institute and Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Karolinska University Hospital, Stockholm, Sweden. michael.ryott@karolinska.se
Background:
Cyclooxygenase-2 expression is associated with unfavorable outcome in various cancers, and evidence is accumulating that carcinogenesis possibly evolves from intracellular changes in response to induction of this enzyme. Today selective cyclooxygenase-2 inhibitors are being studied and used as complement in cancer treatment. This study examined the prognostic value of cyclooxygenase-2 expression in oral tongue squamous cell carcinoma (OTSCC).
Methods:
Expression of cyclooxygenase-2 was determined in biopsies from 76 stage matched patients with OTSCC by immunohistochemistry between January 2000 and December 2004 in Stockholm, Sweden. Additionally, twelve samples taken after pre-operative radiotherapy were investigated.
Results:
All OTSCC specimen expressed cyclooxygenase-2 by immunostaining. The cyclooxygenase-2 staining intensity increased significantly with more advanced stage (P=0.020). Fifty percent of the surgical specimen showed a decrease in immunostaining post-radiation (P=0.031). No association was found with survival.
Conclusion:
Cyclooxygenase-2 expression has limited prognostic value in OTSCC.
Insights
Cyclooxygenase-2 (COX-2) is expressed in oral tongue squamous cell carcinoma (OTSCC). While COX-2 intensity correlates with advanced stage and decreases post-radiation, it does not predict patient survival.
Area of Science:
- Oncology
- Cancer Research
- Immunohistochemistry
Background:
- Cyclooxygenase-2 (COX-2) expression is linked to poor outcomes in various cancers.
- Carcinogenesis may involve intracellular changes driven by COX-2 induction.
- Selective COX-2 inhibitors are explored as adjunct cancer therapies.
Purpose of the Study:
- To investigate the prognostic significance of cyclooxygenase-2 expression in oral tongue squamous cell carcinoma (OTSCC).
Main Methods:
- Immunohistochemistry was used to assess COX-2 expression in 76 stage-matched OTSCC biopsies.
- Samples were collected between January 2000 and December 2004 in Stockholm, Sweden.
- Twelve additional samples were analyzed post-pre-operative radiotherapy.
Main Results:
- All OTSCC specimens exhibited COX-2 expression via immunostaining.
- COX-2 staining intensity significantly increased with tumor stage (P=0.020).
- Post-radiation, 50% of surgical specimens showed reduced COX-2 immunostaining (P=0.031).
- No correlation was found between COX-2 expression and patient survival.
Conclusions:
- Cyclooxygenase-2 expression demonstrates limited prognostic value in oral tongue squamous cell carcinoma.
- Further research may be needed to clarify the role of COX-2 in OTSCC progression and treatment response.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
